-
The presence of aortic valve calcification (AVC) predicts cardiovascular and coronary event risk independent of traditional risk factors and inflammatory biomarkers, likely due to the strong correlation between AVC and subclinical atherosclerosis.
-
Clinical Briefs: Risk for Zoster from the Vaccine in Immunosuppressed Persons, Elucidating the Best, Cerebral Aneurysms: Whats in Your
Patients Future?
-
Off-label prescribing is common in primary care and most of the time lacks the scientific evidence to support it.
-
The ECG was obtained from a patient whose blood pressure was dropping. How many reasons can you cite to support a diagnosis of ventricular tachycardia (VT)?
-
THE FDA HAS APPROVED A SECOND WEIGHT-LOSS DRUG WITHIN the last month. This product is a combination of phentermine, an anorectic, and the antiepileptic topiramate. Phentermine/topiramate (PHEN/TPM) is manufactured by Catalent Pharma Solutions and marketed by Vivus Inc. as Qsymia.
-
-
The FDA has approved a new pancreatic enzyme preparation for the treatment of pancreatic insufficiency. Pancrelipase contains porcine derived lipases, proteases, and amylases. It is marketed by Aptalis Pharma U.S. Inc. as Viokace.
-
-
The authors concluded that ECG LVH and LVH with strain were independently predictive of cardiovascular events, including aortic valve replacement in asymptomatic patients with moderate aortic stenosis.
-
In a double-blind, randomized clinical trial, amoxicillin therapy did not improve outcomes in patients with clinically diagnosed acute rhinosinusitis.
